These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 26362338)
1. Usefulness of intraventricular infusion of antifungal drugs through Ommaya reservoirs for cryptococcal meningitis treatment. Nakama T; Yamashita S; Hirahara T; Okamoto S; Honda S; Watanabe M; Kimura E; Uchino M; Yano S; Kuratsu J; Ando Y J Neurol Sci; 2015 Nov; 358(1-2):259-62. PubMed ID: 26362338 [TBL] [Abstract][Full Text] [Related]
2. The role of an Ommaya reservoir in the management of children with cryptococcal meningitis. Jiang PF; Yu HM; Zhou BL; Gao F; Shen SX; Xia ZZ; Shui QX Clin Neurol Neurosurg; 2010 Feb; 112(2):157-9. PubMed ID: 19910108 [TBL] [Abstract][Full Text] [Related]
3. Clinical characteristic of 15 cases of cryptococcal meningitis treated with Ommaya reservoir. Wan Y; Li X; Wang Y; Yu Y; Yang S Acta Neurol Belg; 2020 Oct; 120(5):1139-1145. PubMed ID: 31321616 [TBL] [Abstract][Full Text] [Related]
4. [A case of cryptococcal meningitis successfully treated with placing Ommaya reservoir into ventricle]. Jiang PF; Zhu T Zhonghua Er Ke Za Zhi; 2005 Jun; 43(6):470-1. PubMed ID: 16053741 [No Abstract] [Full Text] [Related]
5. Ommaya reservoir in the treatment of cryptococcal meningitis. Wei B; Qian C; Liu Y; Lin X; Wan J; Wang Y Acta Neurol Belg; 2017 Mar; 117(1):283-287. PubMed ID: 27492153 [TBL] [Abstract][Full Text] [Related]
6. Cryptococcal meningitis in immunocompetent children. Yuanjie Z; Jianghan C; Nan X; Xiaojun W; Hai W; Wanqing L; Julin G Mycoses; 2012 Mar; 55(2):168-71. PubMed ID: 21762212 [TBL] [Abstract][Full Text] [Related]
7. [Evaluation of low-dose amphotericin B and flucytosine in the treatment of cryptococcal meningitis]. Xu B; Wu JQ; Ou XT; Xie Y; Huang YX; Jiang WM; Jin JL; Zhu LP; Weng XH Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(6):379-81. PubMed ID: 20367933 [TBL] [Abstract][Full Text] [Related]
8. [Effect of implantation of an Ommaya reservoir on prognosis for cryptococcal meningitis]. Huang CF; Yang DY; Wang YC; Lau YJ Zhonghua Yi Xue Za Zhi (Taipei); 1993 Jul; 52(1):36-40. PubMed ID: 8364779 [TBL] [Abstract][Full Text] [Related]
9. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis. Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679 [TBL] [Abstract][Full Text] [Related]
10. A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B. Pitisuttithum P; Tansuphasawadikul S; Simpson AJ; Howe PA; White NJ J Infect; 2001 Nov; 43(4):226-33. PubMed ID: 11869059 [TBL] [Abstract][Full Text] [Related]
11. 'Time-to-amphotericin B' in cryptococcal meningitis in a European low-prevalence setting: analysis of diagnostic delays. Katchanov J; von Kleist M; Arastéh K; Stocker H QJM; 2014 Oct; 107(10):799-803. PubMed ID: 24722846 [TBL] [Abstract][Full Text] [Related]
12. Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries. Loyse A; Thangaraj H; Easterbrook P; Ford N; Roy M; Chiller T; Govender N; Harrison TS; Bicanic T Lancet Infect Dis; 2013 Jul; 13(7):629-37. PubMed ID: 23735626 [TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of the antifungal effect of sertraline in the treatment of cryptococcal meningitis in HIV patients: a single Mexican center experience. Villanueva-Lozano H; Treviño-Rangel RJ; González GM; Hernández-Rodríguez PA; Camacho-Ortiz A; Castillo-Reyna L; Galindo-Alvarado SG; Martínez-Reséndez MF Infection; 2018 Feb; 46(1):25-30. PubMed ID: 28815430 [TBL] [Abstract][Full Text] [Related]
14. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety. Hamill RJ; Sobel JD; El-Sadr W; Johnson PC; Graybill JR; Javaly K; Barker DE Clin Infect Dis; 2010 Jul; 51(2):225-32. PubMed ID: 20536366 [TBL] [Abstract][Full Text] [Related]
15. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Brouwer AE; Rajanuwong A; Chierakul W; Griffin GE; Larsen RA; White NJ; Harrison TS Lancet; 2004 May; 363(9423):1764-7. PubMed ID: 15172774 [TBL] [Abstract][Full Text] [Related]
16. Liposomal amphotericin B (Fungisome) for the treatment of cryptococcal meningitis in HIV/AIDS patients in India: a multicentric, randomized controlled trial. Jadhav MP; Bamba A; Shinde VM; Gogtay N; Kshirsagar NA; Bichile LS; Mathai D; Sharma A; Varma S; Digumarathi R J Postgrad Med; 2010; 56(2):71-5. PubMed ID: 20622383 [TBL] [Abstract][Full Text] [Related]
17. Simultaneous cryptococcal and tuberculous meningitis in a patient with systemic lupus erythematosus. Mete B; Saltoglu N; Vanli E; Ozkara C; Arslan F; Mert A; Ozaras R; Tabak F; Ozturk R J Microbiol Immunol Infect; 2016 Apr; 49(2):289-94. PubMed ID: 23751767 [TBL] [Abstract][Full Text] [Related]
18. Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS. Jaruratanasirikul S Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):719-23. PubMed ID: 9253873 [TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of liposomal amphotericin B in patients with cryptococcal meningitis. Kotwani RN; Gokhale PC; Bodhe PV; Kirodian BG; Kshirsagar NA J Assoc Physicians India; 2001 Nov; 49():1086-90. PubMed ID: 11868862 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and adverse effects of higher dose amphotericin B monotherapy for cryptococcal meningitis in patients with advanced HIV infection. Hsieh SM; Hung CC; Chen MY; Hsueh PR; Chang SC J Microbiol Immunol Infect; 1998 Dec; 31(4):233-9. PubMed ID: 10496164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]